SCHEMBL28250511

SCHEMBL28250511

CCOC(=O)c1c[n+]([O-])ccc1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
POLB P06746 3/20 0.48
LMNA P02545 3/20 0.48
GALR2 O43603 1/20 0.48
MITF O75030 1/20 0.48
HSP90AA1 P07900 1/20 0.48
HPGD P15428 1/20 0.48
XBP1 P17861 1/20 0.48
CCR6 P51684 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
GAA P10253 1/20 0.47
TSHR P16473 1/20 0.44
KMT2A Q03164 2/20 0.43
MAPT P10636 7/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
PKM P14618 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3514702 0.82 TSHR (0.56) ALDH1A1LMNATSHRKMT2AKDM4E
SCHEMBL27006674 0.80 TSHR (0.50) ALDH1A1SMN1; SMN2LMNAHPGDGAA
SCHEMBL5743569 0.77 TSHR (0.50) ALDH1A1LMNAHPGDGAATSHR
SCHEMBL1523174 0.77 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2POLBLMNAGALR2
SCHEMBL8549795 0.77 DTYMK (0.47) ALDH1A1POLBLMNAGAATSHR
SCHEMBL3114745 0.75 KMT2A (0.42) ALDH1A1SMN1; SMN2LMNAGAAKMT2A
SCHEMBL148384 0.75 MAPT (0.56) ALDH1A1SMN1; SMN2POLBLMNAGALR2
SCHEMBL7017758 0.74 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2POLBLMNAGALR2
SCHEMBL13221968 0.74 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2LMNAGAAKMT2A
SCHEMBL14114749 0.74 SMN1; SMN2 (0.61) ALDH1A1SMN1; SMN2POLBLMNAGALR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108770356-A The tricyclic compounds and its preparation of bromodomain protein inhibitor, pharmaceutical composition and purposes 正大天晴药业集团股份有限公司 2018-11-06 CN disclosed